Cargando…
Integrated genomic and DNA methylation analysis of patients with advanced non-small cell lung cancer with brain metastases
BACKGROUND: Brain metastasis is a common and lethal complication of non-small cell lung cancer (NSCLC). It is mostly diagnosed only after symptoms develop, at which point very few treatment options are available. Therefore, patients who have an increased risk of developing brain metastasis need to b...
Autores principales: | Xu, Yanjun, Huang, Zhiyu, Yu, Xiaoqing, Chen, Kaiyan, Fan, Yun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710019/ https://www.ncbi.nlm.nih.gov/pubmed/34952628 http://dx.doi.org/10.1186/s13041-021-00886-4 |
Ejemplares similares
-
A molecular approach integrating genomic and DNA methylation profiling for tissue of origin identification in lung-specific cancer of unknown primary
por: Chen, Kaiyan, et al.
Publicado: (2022) -
Predictive values of genomic variation, tumor mutational burden, and PD-L1 expression in advanced lung squamous cell carcinoma treated with immunotherapy
por: Xu, Yanjun, et al.
Publicado: (2020) -
Lung-molGPA Index Predicts Survival Outcomes of Non-Small-Cell Lung Cancer Patients with Synchronous or Metachronous Brain Metastases
por: Chen, Kaiyan, et al.
Publicado: (2020) -
The correlation between the abundance of EGFR T790M mutation and osimertinib response in advanced non-small cell lung cancer
por: Pan, Guoqiang, et al.
Publicado: (2021) -
Effects of icotinib with and without radiation therapy on patients with EGFR mutant non-small cell lung cancer and brain metastases
por: Fan, Yun, et al.
Publicado: (2017)